Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899)

NCT00044486 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

602

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia, Myelocytic, Acute
Myelodysplastic Syndromes
Neutropenia

Interventions

DRUG: Posaconazole oral suspension

Sponsor

Merck Sharp & Dohme LLC